These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35967)

  • 1. Role of blood platelets in coronary artery disease.
    Haft JI
    Am J Cardiol; 1979 Jun; 43(6):1197-206. PubMed ID: 35967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Platelets and coronary artery disease (CAD) (author's transl)].
    Reimers HJ; Misera R; Schneider W; Loogen F
    Z Kardiol; 1980 Dec; 69(12):799-814. PubMed ID: 7025482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prophylactic value of platelet anti-aggregants in coronary disease].
    Verstraete M
    Clin Ter; 1979 Oct; 91(2):117-27. PubMed ID: 396098
    [No Abstract]   [Full Text] [Related]  

  • 4. Status of antiplatelet drugs in coronary heart disease.
    Mehta J; Mehta P
    JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365
    [No Abstract]   [Full Text] [Related]  

  • 5. Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
    Hirsh J
    Arch Intern Med; 1981 Feb; 141(3 Spec No):311-5. PubMed ID: 7008733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of drugs of platelets and complications of vascular disease.
    Mustard JF; Packham MA; Kinlough-Rathbone RL
    Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448
    [No Abstract]   [Full Text] [Related]  

  • 7. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelets and prostaglandins in sudden death: therapeutic implications.
    Gelman JS; Mehta J
    Cardiovasc Clin; 1985; 15(3):65-80. PubMed ID: 2870807
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).
    Genton E; Gent M; Hirsh J; Harker LA
    N Engl J Med; 1975 Dec; 293(25):1296-300. PubMed ID: 1102986
    [No Abstract]   [Full Text] [Related]  

  • 10. [Platelet antiaggregants and arteriopathies].
    Cristol R
    J Mal Vasc; 1981; 6(3):237-41. PubMed ID: 7026714
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-platelet-aggregating drugs. Clinical pharmacology and therapeutic use].
    Croveri G
    Minerva Cardioangiol; 1980 Oct; 28(10):723-6. PubMed ID: 7465066
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood platelets and myocardial infarction].
    Musiał J; Dworski R; Szczeklik A
    Pol Tyg Lek; 1984 Dec; 39(50):1665-8. PubMed ID: 6396594
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
    Sherry S
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
    Castaldi PA
    Aust N Z J Med; 1981 Dec; 11(6):673-7. PubMed ID: 7036973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet drugs in thromboembolism.
    Hirsh J
    Postgrad Med; 1979 Sep; 66(3):119-23, 126-7. PubMed ID: 382146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet inhibitors in the treatment of thrombosis.
    Hirsh J
    Clin Invest Med; 1978; 1(3-4):191-206. PubMed ID: 391458
    [No Abstract]   [Full Text] [Related]  

  • 17. Are agents affecting platelet function clinically useful in patients with coronary artery disease?
    Verstraete M
    Acta Clin Belg; 1976; 31(4):229-32. PubMed ID: 1087523
    [No Abstract]   [Full Text] [Related]  

  • 18. Controlled ex-vivo effect of sulfinpyrazone on platelet function of myocardial infarction patients.
    Cortellaro M; Fassio G; Boschetti C; Basagni M; Polli EE
    Haematologica; 1979 Apr; 64(2):173-89. PubMed ID: 112008
    [No Abstract]   [Full Text] [Related]  

  • 19. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of platelet-active drugs in coronary artery disease.
    Sherry S
    Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.